Le recours gracieux déposé par le laboratoire PHARMA BLUE concernant le médicament OXBRYTA (voxelotor) est accepté par le collège de la Haute Autorité de Santé.
Voir aussi
Décision d'accès précoce
09/09/2022
Avis et décisions de la HAS
24/06/2022
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
eXBGue8g9wHxKqGX
